---
schema_version: "secwatch.filing_event.v1"
accession: "0001739104-25-000040"
form_type: "8-K"
ticker: "ELAN"
cik: "0001739104"
company_name: "Elanco Animal Health Inc"
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T08:33:48.514683+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Elanco Q1 beats; FY25 revenue raised to $4.51-4.58B; debt paydown accelerated

## Summary
- Q1 revenue $1,193M (-1% reported, +4% organic CC); adj EPS $0.37 vs $0.34 YoY, above guidance.
- FY25 revenue guidance raised to $4,510-$4,580M on FX tailwind; adj EBITDA guidance unchanged at $830-$870M.
- Accelerating debt paydown: gross debt reduction $450-500M expected; net leverage target improved to 3.9x-4.3x.
- Pet Health revenue $635M (-1%); Credelio Quattro ~10% share; Zenrelia in 11,000 clinics (35% penetration).
- Q2 guidance: revenue $1,175-$1,195M, adj EPS $0.17-$0.21; organic constant currency growth 4-6%.

## SEC filing metadata
- accession: 0001739104-25-000040
- form_type: 8-K
- ticker: ELAN
- cik: 0001739104
- company_name: Elanco Animal Health Inc
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739104/000173910425000040/0001739104-25-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739104/000173910425000040/elan-20250507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001739104-25-000040
- JSON: https://secwatch.observer/filing/0001739104-25-000040.json
- Plain text: https://secwatch.observer/filing/0001739104-25-000040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.